C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2602619
Methods of predicting whether an anti-epidermal growth factor receptor ("EGFr")-specific binding agent treatment will be efficacious in treating cancer, and methods of treating patients with anti-EGFr-specific binding agents, are provided, wherein the gene copy number of the EGFr gene is determined.
L'invention concerne des procédés permettant de prévoir si un traitement d'agent de liaison spécifique du récepteur de facteur de croissance anti-épidermique ("EGFr") sera efficace pour le traitement du cancer, ainsi que des procédés de traitement de patients ayant des agents de liaison spécifiques de l'anti-EGFr.
Bardelli Alberto
Moroni Mauro
Siena Salvatore
Amgen Inc.
Bardelli Alberto
Gowling Lafleur Henderson Llp
Moroni Mauro
Siena Salvatore
LandOfFree
Epidermal growth factor receptor gene copy number does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epidermal growth factor receptor gene copy number, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epidermal growth factor receptor gene copy number will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1361835